Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01268592 · ClinicalTrials.gov registry record · NA
Fertility Preservation in Female Cancer Patients
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01268592 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 16 participants.
The verdict
NCT01268592, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to preserve the fertility potential in females diagnosed with cancer by vitrifying (rapidly freezing) their oocytes (eggs) before undergoing treatment for their cancer.
Interventions
- PROCEDURE oocyte vitrification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01268592
The ClinicalTrials.gov registry entry for NCT01268592 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oocyte vitrification is the first listed.
NCT01268592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01268592 about?
NCT01268592 is a clinical study titled "Fertility Preservation in Female Cancer Patients". The purpose of this study is to preserve the fertility potential in females diagnosed with cancer by vitrifying (rapidly freezing) their oocytes (eggs) before undergoing treatment for their cancer.
What is the current status of trial NCT01268592?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2010-10. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01268592?
The interventions under investigation include: oocyte vitrification (PROCEDURE).
Who is sponsoring clinical trial NCT01268592?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.